Print

Progenics Pharmaceuticals, Inc. (PGNX) Presents PSMA-Related Data at SNMMI 2013  
6/11/2013 9:36:52 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

TARRYTOWN, N.Y., June 10, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that it has reported findings from studies of two of its oncology product candidates at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in Vancouver, Canada.

Help employers find you! Check out all the jobs and post your resume.

//-->